Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 2
2018 1
2019 1
2020 2
2021 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
A Call for Standardized Reporting of Adverse Events.
Fankhauser CD, Wettstein MS, Pedregal M, Clarke NW, Sweeney CJ. Fankhauser CD, et al. Among authors: pedregal m. Eur Urol. 2020 Sep;78(3):481-482. doi: 10.1016/j.eururo.2020.06.052. Epub 2020 Jul 4. Eur Urol. 2020. PMID: 32636097 Free article. No abstract available.
Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2.
Paniagua-Herranz L, Moreno I, Nieto-Jiménez C, Garcia-Lorenzo E, Díaz-Tejeiro C, Sanvicente A, Doger B, Pedregal M, Ramón J, Bartolomé J, Manzano A, Gyorffy B, Gutierrez-Uzquiza Á, Pérez Segura P, Calvo E, Moreno V, Ocana A. Paniagua-Herranz L, et al. Among authors: pedregal m. Int J Mol Sci. 2024 Feb 13;25(4):2222. doi: 10.3390/ijms25042222. Int J Mol Sci. 2024. PMID: 38396898 Free PMC article.
A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy.
Fankhauser CD, Tran B, Pedregal M, Ruiz-Morales JM, Gonzalez-Billalabeitia E, Patrikidou A, Amir E, Seidel C, Bokemeyer C, Hermanns T, Rumyantsev A, Tryakin A, Brito M, Fléchon A, Kwan EM, Cheng T, Castellano D, Del Muro XG, Hamid AA, Ottaviano M, Palmieri G, Kitson R, Reid A, Heng DYC, Bedard PL, Sweeney CJ, Connors JM. Fankhauser CD, et al. Among authors: pedregal m. Eur Urol Focus. 2021 Sep;7(5):1130-1136. doi: 10.1016/j.euf.2020.09.017. Epub 2020 Oct 6. Eur Urol Focus. 2021. PMID: 33032968 Free article.
Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors.
Ameratunga M, Chénard-Poirier M, Moreno Candilejo I, Pedregal M, Lui A, Dolling D, Aversa C, Ingles Garces A, Ang JE, Banerji U, Kaye S, Gan H, Doger B, Moreno V, de Bono J, Lopez J. Ameratunga M, et al. Among authors: pedregal m. Eur J Cancer. 2018 Jan;89:56-63. doi: 10.1016/j.ejca.2017.11.012. Epub 2017 Dec 8. Eur J Cancer. 2018. PMID: 29227818 Clinical Trial.
MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer.
Caramés C, Cristobal I, Moreno V, Marín JP, González-Alonso P, Torrejón B, Minguez P, Leon A, Martín JI, Hernández R, Pedregal M, Martín MJ, Cortés D, García-Olmo D, Fernández MJ, Rojo F, García-Foncillas J. Caramés C, et al. Among authors: pedregal m. Int J Mol Sci. 2016 Jun 3;17(6):878. doi: 10.3390/ijms17060878. Int J Mol Sci. 2016. PMID: 27271609 Free PMC article.
Targeting PP2A to overcome enzalutamide resistance in AR+ breast tumors.
Cristóbal I, Torrejón B, Pedregal M, Rojo F, García-Foncillas J. Cristóbal I, et al. Among authors: pedregal m. Endocr Relat Cancer. 2017 Jan;24(1):L5-L6. doi: 10.1530/ERC-16-0444. Epub 2016 Oct 20. Endocr Relat Cancer. 2017. PMID: 27765801 No abstract available.